Microbial evolution and ecological opportunity in the gut environment by Scanlan, Pauline D.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Microbial evolution and ecological opportunity in the gut environment
Author(s) Scanlan, Pauline D.
Publication date 2019-11-20
Original citation Scanlan, P. D. (2019) 'Microbial evolution and ecological opportunity in
the gut environment', Proceedings of the Royal Society B: Biological
Sciences, 286(1915), 20191964. (9pp.) doi: 10.1098/rspb.2019.1964




Access to the full text of the published version may require a
subscription.
Rights ©2019 The Authors. Published by the Royal Society under the terms
of the Creative Commons Attribution License
http://creativecommons.org/licenses/by/4.0/, which permits









Cite this article: Scanlan PD. 2019 Microbial
evolution and ecological opportunity in the gut
environment. Proc. R. Soc. B 286: 20191964.
http://dx.doi.org/10.1098/rspb.2019.1964
Received: 23 August 2019











One contribution to the Special Feature
‘Application of ecological and evolutionary
theory to microbiome community dynamics
across systems’. Guest edited by Dr James
McDonald, Dr Britt Koskella and Professor
Julian Marchesi.
Microbial evolution and ecological
opportunity in the gut environment
Pauline D. Scanlan1,2
1School of Microbiology, and 2APC Microbiome Ireland, Biosciences Building, University College Cork, Cork,
Ireland
PDS, 0000-0002-6733-9653
Recent genomic and metagenomic studies have highlighted the presence of
rapidly evolving microbial populations in the human gut. However, despite
the fundamental implications of this intuitive finding for both basic and
applied gut microbiome research, very little is known about the mode,
tempo and potential functional consequences of microbial evolution in the
guts of individual human hosts over a lifetime. Here I assess the potential
relevance of ecological opportunity to bacterial adaptation, colonization
and persistence in the neonate and germ-free mammalian gut environment
as well as over the course of an individual lifetime using data emerging from
mouse models as well as human studies to provide examples where poss-
ible. I then briefly outline how the continued development and application
of experimental evolution approaches coupled to genomic and metagenomic
analysis is essential to disentangling drift from selection and identifying
specific drivers of evolution in the gut microbiome within and between
individual human hosts and populations.
1. Introduction
Much of gut microbiome research seeks to link microbial diversity with
microbial function and some aspect of the human host phenotype (e.g. health
or specific disease state). Microbial diversity can be conceptualized and studied
at different levels of hierarchy, and the advent of high-throughput sequencing
technologies, culturomics and bioinformatics means that we can now, in prin-
ciple, study variation in diversity at different levels of resolution from the
highest taxonomic levels all the way through to fine-grain analysis at the
strain level within an individual for a considerable proportion of this microbial
community [1–3]. However, until relatively recently the vast majority of gut
microbiome studies that have tried to link microbial diversity and function to
human phenotypes of interest have profiled bacterial diversity at the species
or higher levels of taxonomic resolution (typically genus level due to limited
genetic resolution of common biomarkers e.g. 16S rRNA coupled to short-
read lengths) [4–6]. As a consequence, the extent of variation in microbial diver-
sity within and between individuals is likely to be greatly underestimated.
Moreover, this type of analysis masks the potential presence of dynamic and
rapidly evolving sub-species populations of gut microbes including bacteria
[7] and bacteriophages [8]. Given our knowledge of gut microbial populations’
sizes, rapid generation times and estimated mutation rates the exciting idea that
microbes are rapidly evolving within their human hosts over time-scales of
weeks and months is intuitive [9,10]. However, it is only with the recent publi-
cation of different studies using whole genome sequence analysis of
longitudinally sampled bacterial isolates [7,11,12] and/or high resolution meta-
genomic analysis of bacteria and bacteriophages [8,13] that this obvious but
greatly overlooked reality is being confirmed.
Evolution is defined as genetic change in a population from one generation
to the next. Genetic differences between individuals in microbial populations
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arise from mutational events that can range from single
nucleotide changes, insertions and deletions to recombination
and horizontal gene transfer events. The rise and spread of
novel genetic variants or alleles within a population from
one generation to the next can then occur via random or
non-random evolutionary processes. Random processes
such as genetic drift result in the chance spread of selectively
neutral or nearly neutral mutations in a population or in the
case of genetic draft whereby mutations can hitchhike on a
beneficial genetic background and increase in frequency
[14–16]. Conversely, under natural selection mutations that
confer a benefit (i.e. increase the fitness or reproductive suc-
cess of an individual) can increase in a population due to
the selective advantage they impart [17]. Although we
know virtually nothing about the scale and extent of
microbial evolution in the human gut ecosystem during the
life of an individual and the relative importance of selection
over drift, the ability of microbes to evolve in real-time is
potentially paradigm shifting in terms of how we think
about their functionality—the very simple notion that the
phenotype of an organism can evolve to vary in time and
space has obvious and manifold implications for both basic
and applied gut microbiome research. From the broadest per-
spective, if we are to better understand microbiome diversity
and function within and between human individuals and
populations we require basic knowledge of the mode,
tempo and potential drivers of microbial evolution within
this ecosystem. Addressing this will undoubtedly require
intensive research efforts, but information on microbial evol-
utionary processes in the human gut will allow us to better
understand the relationship between genetic diversification
and microbial function below the species level, help explain
observed phenomena (e.g. the uniqueness of each gut micro-
biome in terms of microbial diversity) and inform the
principles that govern the colonization success, persistence,
stability and resilience of gut microbes and the gut micro-
biome. Moreover, if microbial function can evolve rapidly
within and between individuals then how we think about
and design experiments and gather and interpret data on
the microbiome requires change. Trials and interventions
that aspire to manipulate the microbiota in both health and
disease states may be better planned and more successful
by incorporating an evolutionary perspective.
Several studies have used (meta)genomic comparative
approaches to show that adaptation to host diet has played
a primary role in shaping the microbial diversity of the
human gut over the course of human evolutionary history
[18,19]. However, humans are long-lived hosts and, as
recent publications indicate, within an individual’s lifetime
microbes that inhabit the gut are evolving over short time-
scales of days, weeks and months [7,8,11,12]. As such, it is
conceivable that over a given human lifespan there is suffi-
cient time and opportunity for new strains and species of
microbes to evolve de novo within the human body. In fact,
it has been shown that certain gut bacteriophages are diversi-
fying at a rate that is equivalent to the evolution of a new
phage species within the short time scale of 2 years [8].
Although there are a number of specific factors that can
drive microbial evolution (e.g. parasitism [20]), for this per-
spective I will specifically focus on the potential relevance
of ecological opportunity and its role as a driver of bacterial
evolution and diversification in the gut ecosystem. I will
then briefly outline how complementary analyses that
marry experimental evolution and ecology approaches with
the study of naturally occurring gut communities may pro-
vide the means to bridge the gap from inferring selective
forces and evolutionary processes based on genetic, pheno-
typic and metadata alone to directly studying them in a
controlled, replicated and tractable manner.
2. Ecological opportunity
Although definitions of ecological opportunity have differed
slightly in the literature, a recent review has consolidated
variations on the theme into a precise mechanistic definition
[21]. Ecological opportunity is defined as a prospective, lin-
eage specific characteristic of an environment that contains
both niche availability that enables the persistence of the lin-
eage within an environment and niche discordance which
drives diversifying selection within that lineage [21]. Niche
availability refers to the capacity for a lineage with a particu-
lar phenotype that is new to the community to persist within
that community and niche discordance is what drives diver-
sifying selection due to the discordance or adaptive mismatch
between a lineage’s niche-related traits and the new eco-
logical conditions encountered by the lineage. Ecological
opportunity can therefore arise from changes in the environ-
ment in the lineage’s current location or it can result from the
colonization of a new location by a lineage. Ecological oppor-
tunity encompasses community context and is subject to
changes in both biotic and abiotic components of the environ-
ment. As such, ecological opportunity is a broad term and
ecological opportunity can manifest in multiple forms (e.g.
access to novel resources, extinction of a competitor species
or predator, abiotic stress). Moreover, how a given lineage
responds to ecological opportunity will depend on the diver-
sification potential and the temporal and spatial scale of
heterogeneity in ecological opportunity [21]. Of note, in
vitro microcosm experiments and in vivo mouse models
have shown that bacteria can diversify and adapt in newly
colonized and heterogeneous environments over very short
time scales (days) [22–25].
3. Ecological opportunity in pristine and low
diversity gut environments
Given that individual humans are unique in terms of genetics
and lifestyle (diet, medication, etc.) and show considerable
variation in microbiota composition and species richness
over a lifetime [26,27], ecological opportunity within the
gut ecosystem is likely to vary in time and space within
and between individuals in a population. At birth we can
conceptualize the human gut of each individual as a pristine
or at least depauperate ecosystem [28] that represents a
unique adaptive landscape with considerable ecological
opportunity and potential for adaptive radiation. However,
the adaptive and diversification potential for colonizing
microbes is likely to vary based on the specific microbe(s)
in question, the host immune system and extrinsic factors
relating to birth mode, infant diet and exposure to antibiotics.
For example, the neonate gut can be seeded by microbes from
a range of sources, including maternal (birth canal, faeces,
skin, breast milk) and environmental (hospital setting,





that niche discordance is less for vertically transmitted organ-
isms whose lineages have been faithfully transmitted over
generations between mother and offspring. Here, microbes
that are acquired via passage through the birth canal,
exposure to maternal faeces and/or breast milk may already
be well adapted to the neonate gut environment and ecologi-
cal selection favours their colonization, with perhaps few
mutational events required for these microbes to adapt to
the new host gut. Although we do not have any explicit
studies of ecological opportunity in the human gut we can
consider its relative importance in driving the diversification
of well-recognized vertically transmitted and early colonizers
of the infant gut such as Bifidobacterium spp. [32] compared
with potentially less-well adapted horizontally (environmen-
tally) acquired species. Many infant-associated Bifidobacterium
species (e.g. Bifidobacterium breve, Bifidobacterium bifidum) can
use specific glycans (human milk oligosaccharides) found in
breast milk that cannot be metabolized by the host [33].
This metabolic capacity highlights their adaptedness to the
breastfed infant gut and affords them a considerable ecologi-
cal advantage over other potentially colonizing microbes that
do not possess this trait and therefore may get outcompeted
and cleared from the gut environment more readily in the
absence of other suitable resources they can exploit. While
the reduced time lag potentially afforded by vertical trans-
mission of microbes from mother to infant may contribute
to priority effects, we must also consider that successful
establishment and colonization may then be enhanced via
mutation and selection (i.e. adaptation to the new environ-
ment), which can in turn facilitate persistence within a new
human host. A recent study that used a metagenomics
based approach to track potential vertical transmission
events between mother and infant pairs showed that even
though certain strains of Bifidobacterium detected in the
infant gut at three months post-partum were highly related
to those in the mother and were likely to be vertically
transmitted they had a degree of nucleotide divergence
from the maternal strain [34]. These data may indicate that
although this strain was successfully transmitted from
mother to infant it continued to evolve even over the short
period of three months. Another similar metagenomics-
based study noted the persistence of maternally acquired
strains in the infant gut that had also diverged from the
maternal strain through time which the authors attributed
to strain replacement or mutation [30].
Vertical transmission clearly plays an important role in
colonization success and separate studies have shown that
vertically transmitted strains acquired from the maternal
gut persist for longer (over a four month period) in the
infant gut compared to non-gut and horizontally acquired
strains [35] and that the majority of vertically transmitted
strains detected at high abundance in vaginally delivered
babies at day four post-partum were still present 1 year
later [36]. However, there may be situations where vertical
transmission from mother to infant is negatively affected
[30] (e.g. in infants that are born via C-section, are not
breastfed and where antibiotics have been administered to
mother and/or infant during or after delivery), which in
turn could provide a greater opportunity for horizontally
transmitted microbes to colonize. For example, a recent meta-
genomics study of 596 full-term babies highlighted the
negative impact of C-section delivery and antibiotic prophy-
laxis on the maternal transmission of gut bacteria such as
pioneering Bacteroides species [29]. In such a scenario where
the vertical transmission chain is negatively affected perhaps
mutation and natural selection are crucial to successful colo-
nization of the gut environment for horizontally acquired
microbes. Moreover, if there is sufficient niche availability
but higher niche discordance we might anticipate observing
higher rates of molecular evolution in horizontally acquired
microbes. In line with this reasoning one of the first studies
of microbial evolution in the mammalian gut showed that
elevated mutation rates confer a selective advantage when
colonizing this environment [37]. In this study, Giraud and
co-workers colonized (separately) germ-free mice with two
variants of an Escherichia coli strain (K12 MG1655) that was
isogenic except for mutation rate to explicitly look at how
bacterial mutation rates impact on colonization success in
the gut environment. The E. coli strain used was a laboratory
strain and not isolated from the murine gut and therefore one
could anticipate that niche discordance is certainly higher for
this laboratory strain than a native murine E. coli strain. Intui-
tively, the mutator phenotype was found to be initially
beneficial as it facilitated the supply of adaptive mutations
required for successful colonization and the de novo evolution
of higher bacterial mutation rates during colonization in the
initially non-mutator strain was also observed in a small
subset of the murine hosts (8%, n = 26). However, a higher
mutation rate was no longer beneficial once adaptation was
achieved and mutations accumulated in these bacteria
during colonization were in fact detrimental in secondary
environments. Of note, this phenotype has been reported in
the recent study of microbial evolution in the adult gut
[11]. This finding suggests that an increased mutation rate
is not only beneficial to a bacterial lineage during the coloni-
zation of a new niche but may also be favoured by natural
selection to facilitate adaptability in a lineages current
environment.
Adaptive radiations are a recognized signature of ecologi-
cal opportunity [21,38] and, similar to the aforementioned
mouse model study, others have used strains of E. coli to
explicitly investigate divergence and niche adaptation in the
mammalian gut. One such study monitored genetic changes
associated with E. coli K12 MG1655 colonization and diversi-
fication in the guts of germ-free mice [23,24]. Within a few
days post-inoculation three distinct mutants, each with
unique phenotypes relative to the wild-type and each other,
emerged and stably coexisted over the time scale of the exper-
iment. Mutations in global regulators and genes associated
with motility, carbon source utilization as well as membrane
transport and permeability in response to osmolarity were
observed [23,24]. The pattern of diversification observed
was typical of an adaptive radiation and a trade-off between
resistance to bile salts and nutritional competency was pro-
posed based on the genotypes of evolved bacteria together
with the phenotypic changes in motility and bacterial
growth (fitness) observed under different resource and
stress conditions [24]. Another study that also used E. coli
K12 MG1655 to investigate adaptation to the gut environ-
ment but in a different mouse model (streptomycin-treated
mouse model that in theory and in practice maintains
anaerobic bacteria in the gut) observed differences in the
targets of selection and found mutations primarily in
genes involved in galactitol and sorbitol metabolism as well
as transmembrane transporters [39]. A more recent study





streptomycin-treated mouse model observed even further
differences in the genes under selection compared to those
observed in in vitro and in these aforementioned mouse
models [40]. Here, a lower rate of adaptation compared with
other in vitro and in vivo studies and nomutations in global reg-
ulators were observed. Instead, mutations in the D-galactonate
operon (which facilitated growth on this carbon source in vitro)
and mutations in genes associated with ribosome maturation
were noted.
Collectively, these data emerging from different E. coli-
mouse model evolution studies suggest that the timescales
of the experiment as well as specific experimental details
relating to the mouse model systems may contribute to differ-
ences in the data observed (e.g. in the latter study mutations
in genes associated with ribosome maturation improve bac-
terial growth in the presence of streptomycin which was
added to the mouse drinking water before colonization and
throughout the experiment [40]). However, variation
observed across these different studies also indicate that the
genotype of the colonizing strain and the degree of niche dis-
cordance between it and the environment encountered is also
of critical importance to understanding the likely targets of
selection and the underlying genetics of adaptation associ-
ated with colonization of the gut environment. Interestingly,
while these studies highlight the capacity for different
E. coli strains to rapidly adapt to different models, a recent
study of E. coli evolution in the human gut over several
months did not find any signal of adaptation [12]. What is
particularly intriguing about this contrasting finding is that
it might tell us something about ecological opportunity,
niche discordance and adaptive potential in the gut environ-
ment. Here, researchers sampled E. coli populations from an
individual at three different time points over 315 days and
sequenced 24 isolates of the dominant E. coli (ED1a) strain
within the population. Analysis revealed very little genomic
diversity with no evidence of selection. As outlined this is
in stark contrast to what has been observed in many of the
aforementioned experimental evolution studies using E. coli.
However, given that the strain sequenced was dominant
within the E. coli population of that individual this might
indicate that perhaps this strain is well adapted to its host
and this is why it appears to be evolving neutrally through
time [12]. With respect to this finding the application of an
experimental evolution approach usingmurine strains to colo-
nize murine models may provide more meaningful insight
into ecological opportunity and bacterial adaptation to the
gut environment relative to what has been found in aforemen-
tioned mouse models studies that have used laboratory or
human strains.
Finally, an understanding of how mutation and natural
selection contributes to the relative success of individual
microbes when colonizing a pristine or low diversity gut is
also key to the study of community assembly. However, the
degree to which adaptation can contribute to successful
colonization and in turn priority effects, including niche
pre-emption and niche-exclusion, and ultimately community
assembly and the persistence of microbes in the human
gut while recognized remains unknown [41]. Nonetheless,
evolution-mediated priority effects, also known as mono-
polization, is increasingly recognized as important to the
dynamics of community assembly [42] and has been demon-
strated in experimental microbial populations undergoing
diversifying selection [43].
4. Is ecological opportunity a constant selective
force in the gut over the lifetime of an
individual human host?
Ecological opportunity is perhaps easiest to conceptualize
and study under germ-free and/or depauperate conditions,
and is of clear relevance to our understanding of how
microbial evolution impacts on the colonization and diversi-
fication of microbial species in the neonate and germ-free gut
environment. It is also easy to consider how the spatially
structured nature of the gut, which provides extensive vari-
ation in the physical and chemical environment, hosts a
range of micro-niches that probably impacts on ecological
opportunity. Such micro-niche variation runs both longitud-
inally from the oral cavity to the rectum and radially from
the lumen to the host epithelium and can dictate the local bio-
geography or spatial organization and compositional
variation of microbes at different sites in the gut both in
health and disease [44–46]. However, we must also take a
dynamic perspective and think about how humans are
long-lived hosts and the physical, immunological and physio-
logical changes our bodies undergo [26,47]. For example,
normal development processes affecting the human body,
including key transitions in life-stages (e.g. infancy, child-
hood, adolescence, adulthood and old-age), can all result in
changes to gut surface area and heterogeneity, maturation
and function of the host immune and endocrine systems,
and microbiome complexity [47–50]. Variation in these
factors through time will undoubtedly impose novel diversi-
fying selection pressures on both extant and invading
microbes, and therefore it is likely that there is both sufficient
niche availability and niche discordance for ecological oppor-
tunity to perhaps serve as a constant, or at the very least a
periodic selective force in the gut environment over an
individual human lifetime.
In addition to natural physiological changes another
factor that may affect ecological opportunity is the onset of
a disease or infection that alters the gut environment. Many
high-burden chronic diseases are associated with changes in
both the biotic and abiotic environment of the gut including
altered intestinal motility and immune responses, together
with changes in microbial diversity [51]. Such changes are
characteristic of many common gastrointestinal diseases
including irritable bowel syndrome (IBS) [52] and inflamma-
tory bowel diseases (IBDs) [53]. Moreover, individuals with
diseases such as IBDs and IBS experience periods of remis-
sion and relapse such that there are potential large shifts in
gut environmental variation over relatively short periods of
time [54–56]. Again, the ecological changes associated with
disease and disease onset on the microbiota are relatively
well documented, and diseases such as IBD result in con-
siderable changes in microbial species richness, stability and
composition [57]. Although little is known about how
microbial populations respond to changing environmental
conditions associated with such diseases of the gut from an
evolutionary perspective, within-host adaptation during dis-
ease progression has been well documented in other host
organs such as the human lung. Here, the evolution of par-
ticular bacterial species such as Pseudomonas aeruginosa and
Burkholderia dolosa in the lungs of cystic fibrosis (CF) patients
has been studied and highlights the ability of microbes to





antibiotic treatment [58,59]. For example, a retrospective
study of a B. dolosa outbreak that sequenced isolates from
14 individuals over a 16-year period found signatures of par-
allel adaptive evolution in genes associated with bacterial
membrane composition and antibiotic resistance, as well as
oxygen dependent regulators which highlight the importance
of mutation and selection in driving pathogen virulence
within the human body [58]. In the case of P. aeruginosa,
within-host population diversification in the CF lung results
in a shift from an acute virulence to chronic host adapted
phenotypes through time. Changes in phenotypes are facili-
tated by the evolution of mutator phenotypes, loss of
function mutations in genes associated with quorum sensing
together with selection for increased biofilm formation,
mucoidy and antibiotic resistance [59]. With respect to patho-
gen evolution in the gut environment a recent study looked at
the adaptation of a Crohn’s disease (CD) associated pathogen
to the gut environment during colonization and serial trans-
missions using adherent invasive E. coli (AIEC) in a
streptomycin treated mouse model [60]. A diversity of
AIEC mutants emerged with niche stratification, consistent
with ecological opportunity, identified as the primary selec-
tive force. Different genetic variants emerged including one
lineage that had enhanced acetate utilization relative to the
ancestor and another with hypermotility that facilitated inva-
sion and establishment in a mucosal niche [61]. A particularly
informative aspect of the study was the analysis of 200 single
E. coli isolates taken from 23 CD patient biopsy samples and
25 healthy controls as well as evolved commensal E. coli iso-
lates (E. coli HS) that was used as a control and subjected to
the same experimental regime as AIEC in the experimental
model system. Consistent with the data from the model of
AIEC adaptation to the gut, the collection of isolates obtained
from CD patients, but not the healthy human controls and
evolved E. coli HS isolates, were on average more motile
and had a greater mean generation time when grown on acet-
ate [61]. The strong correlation between the model and in vivo
isolates underscores the biological relevance of the model as
well as providing crucial insight into pathogen evolution
and the differences in evolutionary trajectories of commen-
sals and pathogens of the same species in the gut
environment.
While such changes in human physiology and the biotic
environment through time may serve as an important selec-
tive force perhaps externally derived factors may create the
greatest divergent selection pressures on microbial popu-
lations residing in the human gut. Ecological opportunity is
expected to increase during periods of rapid and varied
environmental changes [21] and the radical changes in
human ecology and lifestyle in recent decades are likely to
have profound impacts on the ecological and evolutionary
selection pressures that shape the diversity and function of
the gut microbiota [62]. The ecological effects of a changing
human lifestyle on gut microbiota composition have been
documented and the microbiome of humans living in Wester-
nized countries such as the US have a greatly reduced
bacterial diversity compared with non-Western human popu-
lations [26,60,63]. However, the evolutionary effects of such
changes on the gut microbiota remain unknown but disturb-
ance events including exposure to lethal selection pressures
such as antibiotics [64] and other medications [65], access to
different resources through changes in diet and exposure to
other xenobiotics [66–69] all have the potential to affect
ecological opportunity by changing environmental and com-
munity context via the provision of novel resources and
habitats to exploit, the removal or invasion of potential com-
petitors or predators and parasites as well as the introduction
of novel abiotic stressors.
Owing to their widespread use in human and agricultural
applications and potentially lethal effects, antibiotics are
probably the most common and severe selection pressure
on bacterial populations [70]. The effects of antibiotic admin-
istration on gut microbiota diversity and composition has
been extensively studied and disturbance events mediated
by antibiotic administration [71] may result in conditions
that support ecological opportunity within the gut environ-
ment. The emergence of antibiotic resistance strains is
common and this has been frequently observed in individuals
that receive large doses of antibiotics in clinical settings.
In a recent study, researchers tracked the evolution of
vancomycin-resistant Enterococcus faecium (VRE) populations
in the gastrointestinal tract of patients undergoing allogeneic
haematopoietic cell transplantation (allo-HCT) and in mouse
models [7]. Genomic data from human and mouse model iso-
lates demonstrated the capacity for rapid evolution of VRE and
highlighted the presence of dynamic subpopulations of VRE
that were diversifying on a daily basis.Manywidely consumed
prescribed and over-the-counter non-antimicrobial medi-
cations are also likely to affect ecological opportunity in the
gut microbiome. A recent study that screened 38 common bac-
terial species against a diverse array of drugs that included 835
human-targeted drugs found that 203 or 24% inhibited
the in vitro growth of at least one bacterial strain with 40
drugs affecting at least ten strains [65]. Similarly, a number of
studies investigating the impact of different medications on
the gut microbiome in vivo have consistently reported changes
in bacterial diversity and relative abundances associated
with non-antimicrobial medications such as metformin [72],
non-steroidal anti-inflammatories [73] and laxatives [74].
Access to novel resources may also afford ecological
opportunity and lead to evolutionary innovations mediated
by horizontal gene transfer (HGT) as evidenced by a study
on the origins of seaweed polysaccharide degrading enzymes
in the gut microbiome of a subset of the Japanese population
[75]. Seaweeds such as Porphyra constitute an important part
of the Japanese diet and genomic analysis identified the pres-
ence of a porphyrin (specific type of carbohydrate in red
seaweeds such as Porphyra) utilization locus of marine
origin in the gut bacterium Bacteroides plebeius (strains of
which have been isolated and sequenced from the intestinal
microbiota of Japanese individuals). The presence of genes
encoding for relaxase/mobilization functions which are
required for conjugative DNA transfer downstream of the
porphyrin utilization locus region identified a probable
mechanism for HGT. Further comparative analysis of
metagenomic datasets from Japanese (n = 13) and North
American individuals (n = 18) identified seven potential
porphyranases and six putative b-agarases (also involved in
seaweed carbohydrate metabolism) in the microbiomes of
four Japanese individuals with no porphyranase or agarase
genes detected in the North American dataset [75]. Here,
ingestion of marine seaweed with associated microbes is pos-
ited to have provided a potential novel niche (i.e. facilitated
ecological opportunity) with evolutionary innovation
mediated by HGT providing access to a novel resource in





5. Linking gut microbiome research with
experimental ecology and evolution
Howwe are born, what we eat, themedications we take, where
we live and our interactions with the environment (as well as
other people and animals) have changed considerably in
recent years and decades. Consequently, both the biotic and
abiotic adaptive landscape of the infant and adult human gut
is likely to have changed considerably in recent times. How
all these factors have and continue to affect ecological opportu-
nity in the gut environment is an open question and
disentangling the factors that drive genetic variation and separ-
ating drift from adaptation in the microbiome at the strain and
species level is very challenging given the multitude of selec-
tion presences that a given human gut microbiome may be
experiencing at any one time. To date, when looking to
detect natural selection and adaptation in microbial popu-
lations, researchers typically look for signals of parallel
evolution and convergence at varying different levels (e.g.
gene, operon and pathway) and/or apply Ka/Ks ratio analysis
to longitudinal and/or cross-sectional genetic data. However,
as alluded to, in the complex abiotic and biotic environment
of the gut, individuals within populations may experience a
multitude of different selection pressures at the one time or
experience single different selection pressures at various differ-
ent time-points. Moreover, ecological context plays a
fundamental role in dictating evolutionary trajectories and as
everyone has an individual host genotype, unique lifestyle
and unique gut microbiota this automatically implies that the
adaptive landscape for similar microbial strains and species
is most likely to differ between the gut environments of indi-
viduals. Additionally, the use of non-synonymous to
synonymous ratios may not always be appropriate as synon-
ymous mutations have been found to have beneficial effects
on fitness in experimental populations of microbes under
strong selection [76,77]. Difficulties associated with trying to
separate signal from noise when looking for signatures of
adaptation in genetic data may be further compounded by
clonal interference, epistasis, elevated mutation rates and hori-
zontal gene transfer events, all of which have been observed in
studies of microbial evolution in the gut environment
[11,37,39,78]. Collectively, these different factors have the
potential to mask signals of a selective force in operation for
a given strain or species within an individual or subset of indi-
viduals within a larger group. As such researchers trying to
identify the targets of selection and the specific and/or general
factors driving adaptation within and between individuals as
well as within and between human populations are often faced
with an extremely difficult task.
However, progress is possible and is being made with
our understanding of microbial evolution in the gut environ-
ment, greatly enhanced by the publication of the mouse
model studies outlined throughout the text [23–25,37,39],
as well as recent studies emerging from the genomic and
metagenomics analysis of the gut microbiota of human popu-
lations [7,11–13,79]. The experimental evolve and re-sequence
approaches coupled to the study of naturally occurring
isolates are particularly powerful, as exemplified by the
aforementioned study that used data derived from their
mouse models studies to direct the phenotypic analysis of
naturally occurring bacteria from the CD gut. This comp-
lementary analysis revealed phenotypic convergence with
selection on traits associated with motility and acetate were
beneficial in a pathogenic genetic background in the gut
environment [61]. However, in addition to mouse models,
which afford the advantage to study the mode and tempo
of microbial evolution in a physiologically complex and bio-
logically relevant gut environment, another possible solution
to better understand how microbes respond to selection and
bridge the gap between the study of single strains in vivo is
the use of chemostat or serial transfer ‘microcosm’
approaches [80–82].
Using chemostats or microcosms one could use faecal
samples, focal species embedded in a complex community
(e.g. faecal sample) or synthetic communities of microbes
composed of diverse species of interest and representative
of naturally occurring communities as inocula depending
on the question and/or microbe(s) of interest at hand. Despite
their lack of spatial structure and biotic complexity (e.g. lack
of host immune system, etc.), these models are powerful
experimental approaches that are used extensively in the
field of microbial evolution owing to their experimental con-
trol, tractability and power of replication [82]. Moreover,
experiments can be run indefinitely, and experimental con-
ditions are potentially infinite, and can be chosen and
manipulated in time and space according to the researcher’s
experimental design. With the lack of host backdrop caveat
in mind, chemostats and microcosms may be particularly
useful to investigate how different abiotic factors, such as
antibiotics and resource availability, affect ecological oppor-
tunity and impact on microbiome evolution, ecology and
function. Chemostat and microcosm experiments may also
be readily applied to the study of how specific biotic inter-
actions such as competition, parasitism (bacteria and
bacteriophages) and predation (protists or bacterivores and
bacteria) can promote or constrain ecological opportunity.
While the data derived from in vitro experiments will be
invaluable in itself, new hypotheses generated can then
be tested in more complex models or can be used to parse
metagenomics datasets for the presence or absence of the
genetic signatures of adaptation uncovered in the exper-
iments. Moreover, recent technological advancements have
seen the development of an ‘intestine-on-a-chip’ that allows
for the co-culture of both individual gut bacterial species
and complex microbial communities containing diverse gut
bacteria (including anaerobic and aerobic species) with
mucous producing human villus intestinal epithelia [83].
Although co-culture experiments were run over short time-
periods (between 3 and 5 days) it was indicated that co-culture
experiments could be run for longer [83]. Crucially, the power
of this model lies in its potential capacity to enable controlled
replicated experiments to be conducted in an environment
that recapitulates many important aspects of the physiology
of the gut microbiome-host interface which is not possible
using chemostats or microcosm approaches.
As is apparent from the text, E. coli is the most widely
used model bacterium to study bacterial evolution in the
gut. The reasons are manifold and linked to its ecological
and clinical relevance together with ease of experimental
and genetic manipulation and tractability. However, further
progress into understanding microbial evolution in the gut
requires us to move beyond focusing on this particular
species and look at evolution in real-time across a broader
range of species. As noted earlier, while rapid adaptive evol-
ution of E. coli is common in vitro and in mouse models no





strain of E. coli in the adult human gut [12]. By contrast the
recent work of Zhao et al. [11] showcased ongoing adaptive
evolution of a taxonomically distant microbe—Bacteroides
fragilis—in the complex environment of the adult gut over
a 2-year period. This study combined the isolation and
sequencing of B. fragilis strains longitudinally sampled from
individual adults coupled to phenotypic assays and meta-
genomic analysis of human population datasets from different
geographical regions [11]. Of note, they found evidence of sub-
ject specific adaptation related to polysaccharide import/
binding but also signatures of adaptation across subjects in
genes associated with cell envelope biosynthesis. With respect
to cell envelope biosynthesis the authors speculated that the
host immune system or evasion of phage predation may be
the selective forces driving these adaptations in the gut. Consist-
ent with the latter hypothesis, an experimental evolution study
that looked at the genomic basis of bacterial adaptation to
phages during coevolution detected multiple different non-
synonymous mutations in genes associated with cell envelope
biogenesis but none in their control populations that were
evolved in the absence of phages [84].
As outlined, researchers working on the gut microbiome
typically take a static perspective where microbial (mainly
bacteria) species are fixed entities with specific functional
traits. While certain functional traits may be fixed at the
species and higher taxonomic levels there may be many
important functional traits that impact on the host phenotype
that are rapidly evolving within and between individuals. An
understanding of what traits are open to and under selection
is key to our understanding of the role of evolution in gut
microbiota function. The key questions we need to address
in future studies should centre on how ongoing microbial
evolution at the sub-species level scales up to higher levels
of microbial interactions and community structure and func-
tion in the context of host health. For example, does microbial
evolution buffer against environmental change and facilitate
functional redundancy? What factors have the potential to
drive or constrain within-host pathogenicity or other clini-
cally relevant phenotypes (e.g. antibiotic resistance)? The
degree to which microorganisms are locally adapted is also
of fundamental importance to understanding community
composition and stability and it may be that strains coloniz-
ing the human gut are typically well adapted to gross
features of the gut environment that are generally common
to all hosts but microbes must continuously evolve to specifi-
cally fine-tune adaptations to their current host or changes in
the host environment to avoid going extinct or being replaced
by a strain that is fitter. On this note, of particular importance
is understanding how evolution plays out over the short term
(weeks and months) versus over the longer term (years
and decades) in the gut (i.e. selection on specific genes and
traits over the short term may be costly in the long term if
conditions changes such that strains may eventually
become lost or replaced within the host or purifying selection
may operate over the long term). Interestingly, perhaps the
first study that capitalized on the availability of metage-
nomics data revealed signatures of drift and purifying
selection as the dominant evolutionary forces in a study
of a subset of the human population [79]. More recently
Garud et al. [13] used a modelling based approach rooted
in population genetic theory to investigate evolutionary
dynamics in the gut microbiome using longitudinal meta-
genomic data from randomly sampled individuals within
the American population, as well as twins. Analysis focused
on 40 dominant bacterial species and although signatures of
strong positive selection for some microbial species within
individuals was evident in the short term the authors noted
that strain replacement was most likely in the long term [13].
To date, the limited knowledge on microbial evolution in
the gut may be due, in part, to a disconnect between disci-
plines (i.e. gut microbiome research and evolutionary
biology) wherebymicrobiome researchers are largely unaware
of the capacity for microbes to evolve in real-time and have
overlooked the potential importance of evolution to their
research. However, the study of evolution in complex commu-
nities is not trivial and technological roadblocks (e.g. low-cost,
high-throughput sequencing is only available in the last
decade) may have stymied progress. Nonetheless, even
though the study of microbial evolution in the gut environ-
ment is only in its infancy recent publications are paving the
way. Importantly, these studies highlight the capacity for
microbes to evolve within the body over very short time
scales and help us conceptualize each human gut as a complex
and varied adaptive landscape in which microbial evolution
occurs. To further progress wemust continue tomove towards
linking knowledge of evolutionary phenomena with applied
research if we are to fully understand the implications of
microbial evolution for gut ecosystem community structure
and function in the context of host health.
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